Form 4: Carlyle Group Sells Shares of QuidelOrtho Corp Under 10b5-1 Trading Plan

The Carlyle Group Inc. reports the sale of QuidelOrtho Corp shares between June 12 and June 13, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• The Carlyle Group Inc. has filed a Form 4 detailing the sale of QuidelOrtho Corp [QDEL] shares.
• The sales occurred on June 12 and 13, 2024.
• The transactions were executed under a Rule 10b5-1 trading plan adopted on May 12, 2024.
• A total of 168,497 shares were sold across multiple transactions at varying prices.
• The weighted average sale prices ranged from $36.8927 to $41.149 per share.
• Following the reported transactions, Carlyle Partners VI Cayman Holdings, L.P. beneficially owns 12,251,686 shares.
• The Carlyle Group Inc. and related entities disclaim beneficial ownership of these securities.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing share sales. It doesn't convey any explicit positive or negative sentiment, reflecting a neutral stance.

Positives

• The sales were conducted under a pre-arranged Rule 10b5-1 trading plan, which can mitigate concerns about insider trading.
• The disclosure is transparent, providing detailed information about the transactions, including the dates, prices, and number of shares sold.

Future Outlook

The document does not contain any specific forward-looking statements regarding QuidelOrtho Corp's future performance or Carlyle Group's future transactions.

Industry Context

This filing reflects ongoing transactions by major shareholders in publicly traded companies. Such transactions are common and are closely monitored by investors to gauge sentiment and potential impact on stock prices.

Stakeholder Impact

• The share sales could potentially impact the stock price of QuidelOrtho Corp, affecting shareholders.
• The transactions may be of interest to employees and other stakeholders of QuidelOrtho Corp.

Key Dates